Halozyme Therapeutics (HALO) Debt Ratio (2013 - 2026)
Halozyme Therapeutics' (HALO) Debt Ratio was 0.83 for Q2 2026, up 13.4% from 0.73 a year earlier and up 3.8% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Debt Ratio (2013 - 2026) Analysis & Trends
For FY2025, Debt Ratio at Halozyme Therapeutics was 0.85, up 16.3% from FY2024.
- By year, Debt Ratio came in at 0.73 in FY2024 (-15.6%), 0.86 in FY2023 (+5.8%), 0.82 in FY2022 (+3.0%) and 0.79 in FY2021 (+15.9%).
- Five-year quarterly Debt Ratio spans a low of 0.06 in Q2 2022 and a high of 0.88 in Q1 2023.
- Year over year, Debt Ratio has now increased in each of the last three quarters, with an average decline of 0.4% over the last eight quarters.
- The high point for year-over-year Debt Ratio in five years was Q3 2022 (growth of 971.7%); the low point was Q2 2022 (a decline of 36.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.80 (Q1 2026), 0.85 (Q4 2025) and 0.68 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 0.83 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.83 |
| Mar 31, 2026 | 0.80 |
| Dec 31, 2025 | 0.85 |
| Sep 30, 2025 | 0.68 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 0.69 |
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | 0.76 |
| Mar 31, 2024 | 0.82 |
| Dec 31, 2023 | 0.86 |
| Sep 30, 2023 | 0.79 |
| Jun 30, 2023 | 0.83 |
| Mar 31, 2023 | 0.88 |
| Dec 31, 2022 | 0.82 |
| Sep 30, 2022 | 0.81 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.08 |
| Dec 31, 2021 | 0.79 |
| Sep 30, 2021 | 0.08 |
API Access
Halozyme Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();